Summary
Albuminuria in Type 1 (insulin-dependent) diabetes is not only an indication of renal disease, but a new, independent risk-marker of proliferative retinopathy and macroangiopathy. The coincidence of generalised vascular dysfunction and albuminuria, advanced mesangial expansion, proliferative retinopathy, and severe macroangiopathy suggests a common cause of albuminuria and the severe renal and extrarenal complications associated with it. Enzymes involved in the metabolism of anionic components of the extracellular matrix (e.g. heparan sulphate proteoglycan) vulnerable to hyperglycaemia, seem to constitute the primary cause of albuminuria and the associated complications. Genetic polymorphism of such enzymes is possibly the main reason for variation in susceptibility.
Article PDF
Similar content being viewed by others
References
Borch-Johnsen K, Kragh Andersen P, Deckert T (1985) The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590–596
Andersen AR, Sandahl Christiansen J, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: An epidemiological study. Diabetologia 25: 496–501
Mogensen CE (1971) Urinary albumin excretion in early and long-term juvenile diabetes. Scand J Clin Lab Invest 28: 183–193
Christensen CK, Mogensen CE (1985) The course of incipient diabetic nephropathy: studies of albumin excretion and blood pressure. Diabetic Med 2: 97–102
Feldt-Rasmussen B, Dinesen B, Deckert M (1985) Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45: 539–544
Ellis EN, Steffes MW, Goetz FC, Sutherland DER, Mauer SM (1986) Glomerular filtration surface in Type 1 diabetes mellitus. Kidney Int 29: 889–894
Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Kverneland A, Frøkjaer Thomsen O (1986) Clinical assessment and prognosis of complication of diabetes. Transplant Proc 18: 1636–1638
Kofoed-Enevoldsen A, Jensen T, Borch-Johnsen K, Deckert T (1987) Incidence of retinopathy in Type 1 (insulin-dependent) diabetes: Association with clinical nephropathy. J Diabetic Complications 3: 96–99
Vigstrup J, Mogensen CE (1985) Proliferative diabetic retinopathy: at risk patients identified by early detection of microalbuminuria. Acta Ophthalmol 63: 530–534
Barnett AH, Dallinger K, Jennings R, Fletcher J, Odugbesan O (1985) Microalbuminuria and diabetic retinopathy. Lancet 1: 53–54
Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL (1986) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: Proteinuria and retinopathy in a population of diabetic persons diagnosed prior to 30 years of age. Diabetic Renal-Retinal Syndrome 3: 245–264
Borch-Johnsen K, Kreiner S (1987) Proteinuria — A predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J 294: 1651–1654
Kannel WB, Stampfer MJ, Castelli WP (1984) The prognostic significance of proteinuria: the Frammingham Study. Am Heart J 108: 1347–1352
Yudkin JS, Forrest RD, Jackson CA (1988) Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 2: 530–533
Damsgaard EM, Frøland A, Mogensen CE (1988) Microalbuminuria is a strong predictor of 6-year mortality of elderly Type 2 (non-insulin-dependent) diabetic patients and non-diabetic subjects. Aprospective study. Diabetologia 31: 483–484A
Nelson RG, Pettitt DJ, Carraher MJ, Baird HR, Knowler WC (1988) The effect of proteinuria on mortality in non-insulin-dependent diabetes mellitus. Diabetes 37: 1499–1504
Schrnitz A, Vaeth M (1988) Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabetic Med 5: 126–134
Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ (1984) Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1: 17–19
Valdorf-Hansen F, Jensen T, Borch-Johnsen K, Deckert T (1987) Cardiovascular risk factors in Type 1 (insulin-dependent) diabetic patients with and without proteinuria. Acta Med Scand 222: 439–444
Telmer S, Sandahl Christiansen J, Andersen AR, Nerup J, Deckert T (1984) Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand 215: 63–68
Stegmayr B, Lithner F (1987) Tobacco and end stage diabetic nephropathy. Br Med J 295: 581–582
Jensen T, Slender S, Deckert T (1988) Abnormalities in plasma concentration of lipoproteins and fibrinogens in Type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 31: 142–145
Mattock MB, Keen H, Viberti GC, El-Gohari MR, Murrels TJ, Scott GS, Wing JR, Jackson PG (1988) Coronary heart disease and urinary albumin excretion rate in Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31: 82–87
Bent-Hansen L, Deckert T (1988) Metabolism of albumin and fibrinogen in Type 1 (insulin-dependent) diabetes mellitus. Diabetes Res 7: 159–164
Feldt-Rasmussen B (1986) Increased transcapillary escape rate of albumin in Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 29: 282–286
Bent-Hansen L, Feldt-Rasmussen B, Kverneland A, Deckert T (1987) Transcapillary escape rate and relative metabolic clearance of glycated and non-glycated albumin in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 2–4
Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T (1987) Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: Incidence and risk factors. Diabetologia 30: 144–148
Leinonen H, Matikainen E, Juntunen J (1982) Permeability and morphology of skeletal muscle capillaries in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 22: 158–162
Dvorak HF, Senger DR, Dvorak AM, Harvey VS, McDonagh J (1985) Regulation of extravascular coagulation by microvascular permeability. Science 227: 1059–1060
Ribes JA; Francis CW, Wagner DD (1987) Fibrin induced release of von Willebrand factor from endothelial cells. J Clin Invest 79: 117–123
Jensen T (1989) Increased plasma level of von Willebrand factor in Type 1 (insulin-dependent) diabetic patients with incipient nephropathy. Br Med J 298: 27–28
Porta M, Townsend C, Clover GM, Nanson M, Alderson AR, McCraw A, Kohner EM (1981) Evidence for functional endothelial cell damage in early diabetic retinopathy. Diabetologia 20: 597–601
Feldt-Rasmussen B, Mathiesen ER, Deckert T, Giese J, Christensen NJ, Bent-Hansen L, Nielsen MD (1987) Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 610–617
Toop MJ, Dallinger KJC, Jennings PE, Barnett AH (1986) Angiotensin-converting enzyme (ACE): relationship to insulin dependent diabetes and microangiopathy. Diabetic Med 3: 455–457
Lieberman J, Sastre A (1980) Serum angiotensin-converting enzyme: Elevations in diabetes mellitus. Ann Intern Med 93: 825–826
Deckert T (1988) Glycemic control and complications. In: Alberti KGMM, Krall LP (eds) The diabetes annual 4. Elsevier Science Publishers, B.V., pp 496–518
Krolewski AS, Warram JH, Christlieb AR et al. (1985) The changing natural history of nephropathy in Type 1 diabetes. Am J Med 78: 785
Feldt-Rasmussen B, Mathiesen ER, Deckert T (1986) Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 2: 1300–1304
Nergaard K, Storm B, Graae M, Feldt-Rasmussen B (1988) Microalbuminuria and retinal changes in children with Type 1 (insulin-dependent) diabetes mellitus are related to long-term poor metabolic control. Diabetologia 31: 527A
Mathiesen ER, Rønn B, Jensen T, Storm B, Deckert T (1988) Microalbuminuria precedes elevation in blood pressure in diabetic nephropathy. Diabetologia 31: 519A
Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA (1987) Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294: 1443–1447
Deckert T, Parving HH, Andersen AR, Sandahl Christiansen J, Oxenbøll B, Svendson PAa, TelmerS, Christy M, Lauritzen T, Froøkjær Thomsen O, Kreiner S, Andersen JR, Binder C, Nerup J (1982) Diabetic nephropathy. A clinical and morphometric study. In: Eschwege E (ed) Diabetes epidemiology. Elsevier Biomedical Press B.V., pp 235–243
Bank N, Klose R, Aynedjian HS, Nguyen D, Sablay LB (1987) Evidence against increased glomerular pressure initiating diabetic nephropathy. Kidney Int 31: 898–905
Mauer SM, Steffes MW, Azar S, Brown DM (1988) Thoughts on the pathogenesis of diabetic nephropathy. Diabete Metab 14: 206
Anderson S, Brenner BM (1988) Pathogenesis of diabetic glomerulopathy: Hemodynamic considerations. Diabetes Metab Rev 2: 163–177
Svejgaard A, Jakobsen BK, Platz P, Ryder LP, Nerup J, Christy M, Borch-Johnsen K, Parving HH, Deckert T, Mølsted-Pedersen L, Kühl C, Buschard K, Green A (1986) HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens 28: 237–244
Seaquist ER, Goetz FC, Rich S, Barbosa J (1987) Concordance for nephropathy in diabetic siblings: Evidence of genetic susceptibility to diabetic kidney disease. Diabetes 36: [Suppl]: 105A
Krolewski AS, Canessa M, Warram JH, Laffel LMB, Christlieb R, Knowler WC, Rand LI (1988) Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Eng J 3: 140–145
Mangili R, Bending JJ, Scott G, Li LK, Gupta A, Viberti GC (1988) Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J 3: 146–150
Viberti GC, Keen H, Wiseman MJ (1987) Raised arterial pressure in parents of proteinuric insulin dependent diabetics. Br Med J 295: 515–517
Rohrbach DH, Wagner CW, Star VL, Martin GR, Brown KS, Yoon JW (1983) Reduced synthesis of basement membrane heparan sulfate proteoglycan in streptozotocin-induced diabetic mice. J Biol Chem 19: 11672–11677
Schleicher E, Wieland OH (1984) Changes of human glomerular basement membrane in diabetes mellitus. J Clin Chem Clin Biochem 22: 223–227
Shimomura H, Spiro RG (1987) Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes. Diabetes 36: 374–381
Wu V-Y, Wilson B, Cohen MP (1987) Disturbances in glomerular basement membrane glycosaminogylcans in experimental diabetes. Diabetes 36: 679–683
Viberti GC, Keen H (1984) Relevance to pathogenesis and prevention of diabetic nephropathy. Diabetes 33: 686–692
Hawthorne GC, MacLellan JR, Mythen M, Alberti KGMM, Turner GA (1986) Studies on glomerular basement membrane in experimental diabetes using lectin histochemistry in Wistar rats. Diabetologia 29: 495–499
Cohen MP, Klepser H, Wu V-Y (1988) Undersulfation of glomerular basement membrane heparan sulfate in experimental diabetes and lack of correction with aldose reductase inhibition. Diabetes 37: 1324–1327
Bray J, Robinson G (1984) Influence of charge on filtration across renal basement membrane films in vitro. Kidney Int 25: 527–533
Kanwar YS, Veis A, Kimura JH, Jakubowski ML (1984) Characterization of heparan sulfate-proteoglycan of glomerular basement membranes. Proc Natl Acad Sci 81: 762–766
Stow JL, Sawada H, Farquhar MG (1985) Basement membrane heparan sulfate proteoglycans are concentrated in the laminae rarae and in podocytes of the rat renal glomerulus. Proc Natl Acad Sci 82: 3296–3300
Kverneland A, Feldt-Rasmussen B, Vidal P, Welinder B, Bent-Hansen L, Søegaard U, Deckert T (1986) Evidence of changes in renal charge selectivity in patients with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 29: 634–639
Kverneland A, Welinder B, Feldt-Rasmussen B, Deckert T (1988) Improved metabolic control does not alter the charge-dependent glomerular filtration of albumin in uncomplicated Type 1 (insulin-dependent) diabetes. Diabetologia 31: 708–710
Vidal P, Welinder BS, Deckert T, Hansen B (1988) Charge heterogeneity of glycated human serum albumin. In: Schafer-Nielsen C (ed) Proceedings. VCH Verlagsgesellschaft, Weinheim, pp 468–473
Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M (1988) Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int 33: 100–106
Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M (1987) Glomerular size and charge selectivity in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 513A
Nakamura Y, Myers BD (1988) Charge selectivity of proteinuria in diabetic glomerulopathy. Diabetes 37: 1202–1211
Houhala IA, Pastennack A (1987) Fractional dextran and protein clearances in glomerulonephritis and in diabetic nephropathy. Clin Sci 72: 289–296
Tomlanovich SJ, Jones HW, Meyers BD (1986) Glomerular capillary wall dysfunction in progressive diabetic nephropathy. Diab Neph 5: 23–26
Vernier RL, Sisson-Ross S, Mauer SM (1986) Cytochemical studies of the anionic changes in the kidney in Type 1 diabetes mellitus. Diab Neph 5: 15–18
Rohrbach R (1986) Reduced content and abnormal distribution of anionic sites (acid proteoglycans) in the diabetic glomerular basement membrane. Virchows Arch (Cell Pathol) 51: 127–135
Morikawa A, Watanabe K, Ishii K (1987) A study of anionic sites in glomerular basement membrane (GBM) in the spontaneously diabetic Chinese hamsters of Asahikawa Colony (CHA). Diabetes 36 [Suppl] 1: 106A
Caldwell RB, Slapnick SM; McLaughlin BJ (1986) Decreased anionic sites in Bruch's membrane of spontaneous and drug-induced diabetes. Invest Ophthalmol Vis Sci 27: 1691–1697
Gambaro G, Baggio B, Cicerello E, Mastrosimone S, Marzaro G, Borsati A, Crepaldi G (1988) Abnormal erythrocyte charge in diabetes mellitus. Diabetes 37: 745–748
Raz I, Havivi Y, Yarom R (1988) Reduced negative surface charge on arterial endothelium of diabetic rats. Diabetologia 31: 618–620
Kanwar YS, Faraquhar MG (1979) Presence of heparan sulfate in glomerular basement membrane. Proc Natl Acad Sci 76: 1303–1307
Heickendorff L, Ledet T (1984) Glycosaminoglycans of arterial basement membrane-like material from cultured rabbit aortic myomedial cells. Bichim Biophys Acta 798: 276–282
Kanwar YS, Jakubowski MI, Rosenzweig IJ (1983) Distribution of sulfated glycosamingoglycans in the glomerular basement membrane and mesangial matrix. Eur J Cell Biol 31: 290–295
Robinson J, Gospodarowicz D (1984) Effect of p-Nitrophenyl-β-D-xyloside on proteoglycan synthesis and extracellular matrix formation by bovine corneal endothelial cell cultures. J Biol Chem 259: 3818–3824
Rosenzweig LJ, Kanwar YS (1982) Removal of sulfated (heparan sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I-bovine serum albumin. Lab Invest 47: 177–183
Groggel GC, Stevenson J, Hovingh P, Linker A, Border WA (1988) Changes in heparan sulfate correlate with increased glomerular permeability. Kidney Int 33: 517–523
Cotran RS, Rennke HG (1983) Anionic sites and the mechanisms of proteinuria. N Engl J 309: 1050–1052
Gallagher JT, Lyon M, Steward WP (1986) Structure and function of heparan sulphate proteoglycans. Biochem J 236: 313–325
Tarsio JF, Reger LA, Furcht LT (1988) Molecular mechanisms in basement membrane complications of diabetes. Diabetes 37: 532–539
Hunsicker LG, Shearer TP, Shaffer SJ (1981) Acute reversible proteinuria induced by infusion of the polycation hexadimethrine. Kidney Int 20: 7–17
Castellot JJ, Hoover RL, Harper PA, Karnovsky MJ (1985) Heparin and glomerular epithelial cell-secreted heparin-like species inhibit mesangial-cell proliferation. Am J Pathol 120: 427–435
Purkerson ML, Tollefsen DM, Klahr S (1988) N-desulfated/acetulated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation. J Clin Invest 81: 69–74
Marcum JA, McKenney JB, Rosenberg RD (1984) Acceleration of thrombin-antithrombin complex formation rat hindquarters via heparin-like molecules bound to the endothelium. J Clin Invest 74: 341–350
Marcum JA, Atha DH, Fritze LMS, Nawroth P, Stern D, Rosenberg RD (1986) Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate progeoglycan. J Biol Chem 261: 7507–7517
Pejler G, Bäckström G, Lindahl U (1987) Structure and affinity for antithrombin of heparan sulfate chains derived from basement membrane proteoglycans. J Biol Chem 262: 5036–5043
Marcum JA, Fritze L, Galli SJ, Karp G, Rosenberg RD (1984) Microvascular heparin-like species with anticoagulant activity. Am J Physiol 245: H725-H733
Ishibashi T, Tanaka K, Taniguchi Y (1981) Platelet aggregation and coagulation in the pathogenesis of diabetic retinopathy in rats. Diabetes 30: 601–606
Dallinger KJC, Jennings PE, Toop MJ, Gyde OHB, Barnett AH (1987) Platelet aggregation and coagulation factors in insulin dependent diabetics with and without microangiopathy. Diabetic Med 4: 44–48
Deuel TF, Huang JS (1984) Platelet-derived growth factor: structure, function and roles in normal and transformed cells. J Clin Invest 74: 669–676
Abboud HE, Poptic E, DiCorleto P (1987) Production of platelet-derived growth factor-like protein by Rat Mesangial cells in culture. J Clin Invest 80: 675–683
Donadio JV, Ilstrup DM, Holley KE, Romero JC (1988) Platelet-inhibitor treatment of diabetic nephropathy: A 10-year prospective study. Mayo Clin Proc 63: 3–15
Williams MP, Streeter HB, Wusteman FS, Cryer A (1983) Heparan sulphate and the binding of lipoprotein lipase to porcine thoracic aorta endothelium. Biochim Biophys Acta 756: 83–91
Staprans I, Felts JM, Couser WG (1987) Glycosaminoglycans and chylomicron metabolism in control and nephrotic rats. Metabolism 36: 496–501
Castellot JJ, Beeler DL, Rosenberg RD, Karnowsky MJ (1984) Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. J Cell Physiol 120: 315–320
Dybdahl H, Ledet T (1987) Diabetic macroangiopathy. Diabetologia 30: 882–886
Slender S, Hjelms E (1987) In vivo transfer of cholesterol from plasma into human aortic tissue. Scand J Clin Lab Invest 47: 21–29
Berenson GS, Radhakrishnamurthy B, Srinivasan SR, Vijayagopal P, Dalferes ER, Sharma C (1984) Recent advances in molecular pathology. Exp Mol Pathol 41: 267–287
Kanwar YS, Rosenzweig LJ, Linker A, Jakubowski ML (1983) Decreased de novo synthesis of glomerular proteoglycans in diabetes: Biochemical and autoradiographic evidence. Proc Natl Acad Sci 80: 2272–2275
Hassel JM, Noonan DM, Ledbetter SR, Laurie GW (1986) Biosynthesis and structure of the basement membrane proteoglycan containing heparan sulphate side-chains. In: Evered D, Whelan J Functions of the proteoglycans. John Wiley & Sons, Chichester New York Brisbane Toronto, pp 204–222
Lindahl U, Höök M (1978) Glycosaminogylcans and their binding to biological macromolecules. Annu Rev Biochem 47: 385–417
Graham JM, Winterbourne DJ (1988) Subcellular localization of the sulphation reaction of heparan sulphate synthesis and transport of the proteoglycan to the cell surface in rat liver. Biochem J 252: 437–445
Lindahl U, Feingold DS, Rodén L (1986) Biosynthesis of heparin. TIBS 11: 221–225
Kjellén L, Bielefeld D, Hook M (1983) Reduced sulfation of liver heparan sulfate in experimentally diabetic rats. Diabetes 32: 337–342
Spiro MJ (1987) Sulfate metabolism in the alloxan-diabetic rat: relationship of altered sulfate pools to proteoglycan sulfation in heart and other tissues. Diabetologia 30: 259–267
Klein JD, Brown DM, Oegema TR (1986) Glomerular proteoglycans in diabetes. Diabetes 35: 1130–1142
Levy P, Picard J, Bruel A (1984) Evidence for diabetes-induced alterations in the sulfation of heparan sulfate in intestinal epithelial cells. Life Sci 35: 2613–20
Eriksson UJ, Kjellén L, Unger E (1986) Decreased levels of high molecular weight proteoglycan in diabetic rats of a malformation prone strain. Diabetologia 29: 545A
Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC (1984) Structural-functional relationships in diabetic nephropathy. J Clin Invest 74: 1143–1155
Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T (1989) Features of endothelial dysfunction in early diabetic nephropathy. Lancet I: 461–463
Author information
Authors and Affiliations
Additional information
Given by T.Deckert as Claude Bernard lecture, Paris 1988
Rights and permissions
About this article
Cite this article
Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K. et al. Albuminuria reflects widespread vascular damage. Diabetologia 32, 219–226 (1989). https://doi.org/10.1007/BF00285287
Issue Date:
DOI: https://doi.org/10.1007/BF00285287